Reducing Antacid Use in a Level IV NICU: A QI Project to Reduce Morbidity

INTRODUCTION: Gastroesophageal reflux is a physiologic occurrence in infants. Clinicians caring for neonates use histamine-2 receptor antagonists (H2As) or proton pump inhibitors (PPIs) for symptomatic reflux, apnea/bradycardia/desaturations, or irritability. Recent studies have shown that there is...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Pediatr Qual Saf
Auteurs principaux: Reinhart, Richelle M., McClary, Jacquelyn D., Zhang, Mengqi, Marasch, Jaime L., Hibbs, Anna Maria, Nock, Mary L.
Format: Artigo
Langue:Inglês
Publié: Wolters Kluwer Health 2020
Sujets:
Individual QI Projects from Single Institutions
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7297399/
https://ncbi.nlm.nih.gov/pubmed/32607459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/pq9.0000000000000303
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires